Biotech firm 'boosts client base' with distribution deal

A biotechnology firm has secured a European and North African distribution deal.

Atelerix is working with CliniSciences.

Officials say the agreement will “significantly bolster its customer base” by strengthening European delivery and technical support channels, as well as establishing a North African presence.

Based in The Biosphere, on Newcastle’s Helix development, Atelerix is known for hypothermic gel-based technology that preserves live cells, tissues and viruses.

CliniSciences operates as a distributor for the life science research and diagnostics sector, specialising in reagents and instruments for immunology, cell biology and molecular biology. 

Alastair Carrington, Atelerix chief executive, said: “With its established customer base and extensive team of technical experts across the continent, CliniSciences was the obvious choice of partner.

“Together, we are not only strengthening our presence in these key regions, but removing barriers to adoption.”

Wilfried Gay, CliniSciences’ scientific manager, added: “Atelerix’s patented hydrogels offer a unique approach to cell preservation and the transport of other temperature-sensitive biological substances. 

“This partnership will allow us to bring these innovative cell preservation solutions to customers, and let them focus on what is most important to them – advancing ground-breaking research.”

Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →

Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.